Filer Snapshot

Odonate Therapeutics, Inc.

CIK 0001717452. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.

Entity type

Company

Total filings

405

Latest filing

14 Feb 2022

Industry

Pharmaceutical Preparations

Filing-backed research brief

Start with the SEC data that changes for this CIK

Latest signal: SEC filing timeline only. Each card links back to the PortfolioSavvy page where the filing evidence is closest.

Go to filings Save page

Largest parsed holding

—

Populates from the latest parsed 13F information table.

Open holding

13D/G large stake

—

No recent parsed 13D/G stake row for this CIK.

Browse 13D/G

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Create free account and save this filer Already have an account? Sign in and save it
Source: SEC Schedule 13D/G

SC 13G/A filed on 14 Feb 2022 for CIK 0001717452.

View source filing
At a glance Names, identifiers, and filing context for this profile. 2 identity fields
SEC industry group
Pharmaceutical Preparations (Office of Life Sciences)
Business address
3 East 28 Th Street, 10 Th Floor, New York, NY, 10016
EDGAR profile Static EDGAR fields kept behind disclosure so the main profile stays readable. 3 profile fields available
Incorporated in
DE
Fiscal year end
31 December
Former names on EDGAR
Odonate Therapeutics, LLC (to 06 Dec 2017)

Filer intelligence

What SEC filings say about Odonate Therapeutics, Inc.

A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.

Save filer

SEC source mix

Counts show available parsed rows, not one combined ownership total.

No XML rows yet
13F portfolio No rows yet

Quarterly institutional portfolio holdings.

13D/G stakes No rows yet

Beneficial ownership and large-stake disclosures.

Forms 3/4/5 No rows yet

Officer, director, and 10% owner holdings or transactions.

No parsed ownership summary yet

We still show the SEC filing timeline below. The intelligence summary will populate when parsed 13F, 13D/G, or Forms 3/4/5 data exists for this CIK.

SEC filing record

CIK 0001717452 filing coverage

Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.

SEC filings
405
First seen
29 Sep 2017
Latest filing
14 Feb 2022
Entity
Company

Observed form types

SC 13G/A 15-12B EFFECT SC 13G S-8 POS POS AM 25-NSE 8-K 4 SC 13D/A +21 more

CIK-linked evidence first

Odonate Therapeutics, Inc. SEC filings Odonate Therapeutics, Inc. insider transactions Open SEC filing index

Industry context: Pharmaceutical Preparations.

Latest Filings

Showing the latest 12 of 405 SEC filings for Odonate Therapeutics, Inc..

Open full filing history
SC 13G/A File 005-90212

SC 13G/A

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90212

JANUS HENDERSON GROUP PLC OWNS 0%

Filing date
10 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
15-12B File 001-38318

15-12B

Filing date
07 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-250993

EFFECT filing

Filing date
28 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-233990

EFFECT filing

Filing date
28 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-229785

EFFECT filing

Filing date
28 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90212

NONE

Filing date
28 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90212

NONE

Filing date
28 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-234529

S-8 POS

Filing date
26 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-250993

POS AM

Filing date
26 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-224175

S-8 POS

Filing date
26 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-233990

POS AM

Filing date
26 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .